RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
|
|
|
-
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.
Authors: G J S Cooper, A A Young, G D Gamble, C J Occleshaw, A M Dissanayake, B R Cowan, D H Brunton, J R Baker, A R J Phillips, C M Frampton,…
Diabetologia 2009 Apr -
Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.
Authors: J Lu, D Gong, S Y Choong, H Xu, Y-K Chan, X Chen, S Fitzpatrick, S Glyn-Jones, S Zhang, T Nakamura,…
Diabetologia 2010 Mar 11
Thought leaders and organizations working on research involving trientine.
- National Center for Research Resources (NCRR)
- Cancer Research UK
- University of Auckland
- University of Michigan Medical School
- Rakuno Gakuen University
- Nara Medical University
- King's College London School of Medicine at King's College Hospital NH…
-
Study of Tetrathiomolybdate in Patients With Wilson Disease
conditions: Wilson Disease
interventions: tetrathiomolybdate ; trientine
-
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
conditions: Breast Cancer
interventions: SOD1 inhibitor ATN-224 ; exemestane ; protein expression analysis ; proteomic profiling ; laboratory biomarker analysis ; pharmacological study
Community
